Authors:
JOHNSON CA
KILPATRICK D
VONROEMELING R
LANGER C
GRAHAM MA
GREENSLADE D
KENNEDY G
KEENAN E
ODWYER PJ
Citation: Ca. Johnson et al., PHASE-I TRIAL OF TIRAPAZAMINE IN COMBINATION WITH CISPLATIN IN A SINGLE-DOSE EVERY 3 WEEKS IN PATIENTS WITH SOLID TUMORS, Journal of clinical oncology, 15(2), 1997, pp. 773-780
Authors:
GRAHAM MA
SENAN S
ROBIN H
ECKHARDT N
LENDREM D
HINCKS J
GREENSLADE D
RAMPLING R
KAYE SB
VONROEMELING R
WORKMAN P
Citation: Ma. Graham et al., PHARMACOKINETICS OF THE HYPOXIC CELL CYTOTOXIC AGENT TIRAPAZAMINE ANDITS MAJOR BIOREDUCTIVE METABOLITES IN MICE AND HUMANS - RETROSPECTIVEANALYSIS OF A PHARMACOKINETICALLY GUIDED DOSE-ESCALATION STRATEGY IN A PHASE-I TRIAL, Cancer chemotherapy and pharmacology, 40(1), 1997, pp. 1-10
Authors:
FOX PA
LIVELY JD
FIRTH JW
WOOLFREY SG
GREENSLADE D
Citation: Pa. Fox et al., A SENSITIVE ASSAY FOR CYCLOPHOSPHAMIDE IN HUMAN PLASMA UTILIZING MASS-SPECTROSCOPY, Journal of liquid chromatography & related technologies, 19(7), 1996, pp. 1047-1059
Citation: D. Greenslade, LETTERS -ARTICLE ON LLOYD,DAVID ANTHOLOGY THE 'URGENCY OF IDENTITY'( RESPONSE TO STEVENSON,ANNE REVIEW), Poetry Wales, 31(4), 1996, pp. 4-5
Authors:
WOOLFREY SG
HEGBRANT J
THYSELL H
FOX PA
LENDREM DW
LOCKWOOD GF
LASHER K
ROGERS J
GREENSLADE D
Citation: Sg. Woolfrey et al., DOSE REGIMEN ADJUSTMENT FOR MILRINONE IN CONGESTIVE-HEART-FAILURE PATIENTS WITH MODERATE AND SEVERE RENAL-FAILURE, Journal of Pharmacy and Pharmacology, 47(8), 1995, pp. 651-655